Novartis joins fight against malaria

Novartis has become the first healthcare company to join United Against Malaria (UAM), a pan-Africa campaign to end malaria-related deaths and suffering by 2015....

Best-selling drugs cheaper in Europe

European prices of 170 best-selling drugs averaged 40% less than US prices in 2008, recent research has revealed. Within Europe, it was found,...

Study confirms Cervarix efficacy

The largest efficacy trial of a cervical cancer vaccine has shown that Cervarix protects against the five most common cancer-causing virus types. The...

Positive CHMP opinion for Javlor

The CHMP has issued a positive opinion recommending EU marketing authorisation for Javlor from Laboratoires Pierre Fabre. The drug has been recommended for...

EU lung cancer approval for Alimta

Alimta (pemetrexed for injection) has become the first agent approved in Europe as maintenance therapy for advanced, nonsquamous non-small cell lung cancer. The European...

Scientists recognised for Alzheimer’s research

Four scientists have been recognized by the Alzheimer’s Association for their extraordinary achievements in advancing Alzheimer's research at its 2009 International Conference on Alzheimer's...

Big pharma goes legally blonde

Reese Witherspoon is to produce and star in a new comedy about a woman’s career within the drug industry. Currently under development by Universal...

Security,Opportunity,Success: how Ashfield In2Focus can help you build a career

Pharmaceutical companies are downsizing, but one UK company keeps getting bigger. Ashfield In2Focus shows how its commitment to personal and professional development is providing...

Latest articles

Roche's Hemlibra® available on NHS

NHS England makes Roche’s Hemlibra® available on NHS

NHS England has made Roche's Hemlibra® available on NHS. It is to fund the “life-changing treatment” for thousands of people with severe Haemophilia, which...
Responding to the UK Prime Minister's committment to improving declining vaccination rates, the ABPI said tackling vaccine hesitancy should be a priority.

ABPI says prioritise ‘vaccine hesitancy’ as UK loses measles-free status

Responding to the news that the UK Prime Minister has committed to improving declining vaccination rates, Dr Sheuli Porkess, Executive Director at the ABPI,...
AbbVie receives FDA approval of RINVOQ™

AbbVie receives FDA approval of RINVOQ™

The U.S. Food and Drug Administration (FDA) has approved AbbVie's RINVOQ™ (upadacitinib), a 15 mg, once-daily oral Janus kinase (JAK) inhibitor, for the treatment...

Popular articles

Roche's Hemlibra® available on NHS

NHS England makes Roche’s Hemlibra® available on NHS

NHS England has made Roche's Hemlibra® available on NHS. It is to fund the “life-changing treatment” for thousands of people with severe Haemophilia, which...
Building blocks: Building trust with sales representatives

Building trust in health with sales representatives

Paul Terry explores how the sales representative is best placed to build trust with the health sector, and how industry needs to adapt to...
The Cabinet Office and Department of Health and Social Care have published their Prevention Green Paper, Advancing our health: prevention in the 2020s. It sets out plans to tackle the causes of preventable ill health in England.

Prevention Green Paper published – Advancing our health: prevention in the 2020s

The Cabinet Office and Department of Health and Social Care have published their Prevention Green Paper, Advancing our health: prevention in the 2020s. It...
pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
AbbVie receives FDA approval of RINVOQ™

AbbVie receives FDA approval of RINVOQ™

The U.S. Food and Drug Administration (FDA) has approved AbbVie's RINVOQ™ (upadacitinib), a 15 mg, once-daily oral Janus kinase (JAK) inhibitor, for the treatment...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription